IBDEI0PJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11479,1,3,0)
 ;;=3^Left Ventricular Failure
 ;;^UTILITY(U,$J,358.3,11479,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,11479,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,11480,0)
 ;;=E21.3^^46^556^17
 ;;^UTILITY(U,$J,358.3,11480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11480,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,11480,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,11480,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,11481,0)
 ;;=E78.5^^46^556^16
 ;;^UTILITY(U,$J,358.3,11481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11481,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,11481,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,11481,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,11482,0)
 ;;=M10.30^^46^556^11
 ;;^UTILITY(U,$J,358.3,11482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11482,1,3,0)
 ;;=3^Gout d/t Renal Impairment,Unspec Site
 ;;^UTILITY(U,$J,358.3,11482,1,4,0)
 ;;=4^M10.30
 ;;^UTILITY(U,$J,358.3,11482,2)
 ;;=^5010356
 ;;^UTILITY(U,$J,358.3,11483,0)
 ;;=E66.9^^46^556^33
 ;;^UTILITY(U,$J,358.3,11483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11483,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,11483,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,11483,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,11484,0)
 ;;=E66.01^^46^556^32
 ;;^UTILITY(U,$J,358.3,11484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11484,1,3,0)
 ;;=3^Obesity,Morbid,d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,11484,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,11484,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,11485,0)
 ;;=D50.9^^46^556^2
 ;;^UTILITY(U,$J,358.3,11485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11485,1,3,0)
 ;;=3^Anemia,Iron Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,11485,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,11485,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,11486,0)
 ;;=D63.1^^46^556^1
 ;;^UTILITY(U,$J,358.3,11486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11486,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,11486,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,11486,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,11487,0)
 ;;=G60.9^^46^556^31
 ;;^UTILITY(U,$J,358.3,11487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11487,1,3,0)
 ;;=3^Neuropathy,Hereditary/Idiopathic,Unspec
 ;;^UTILITY(U,$J,358.3,11487,1,4,0)
 ;;=4^G60.9
 ;;^UTILITY(U,$J,358.3,11487,2)
 ;;=^5004071
 ;;^UTILITY(U,$J,358.3,11488,0)
 ;;=I73.9^^46^556^34
 ;;^UTILITY(U,$J,358.3,11488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11488,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,11488,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,11488,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,11489,0)
 ;;=N04.9^^46^556^30
 ;;^UTILITY(U,$J,358.3,11489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11489,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,11489,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,11489,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,11490,0)
 ;;=N25.0^^46^556^35
 ;;^UTILITY(U,$J,358.3,11490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11490,1,3,0)
 ;;=3^Renal Osteodystrophy
 ;;^UTILITY(U,$J,358.3,11490,1,4,0)
 ;;=4^N25.0
 ;;^UTILITY(U,$J,358.3,11490,2)
 ;;=^104747
 ;;^UTILITY(U,$J,358.3,11491,0)
 ;;=T80.211A^^46^556^3
 ;;^UTILITY(U,$J,358.3,11491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11491,1,3,0)
 ;;=3^Bloodstream Infection d/t Central Venous Catheter,Init Encntr
